Thomas Willem Johannes Huizinga

1 Patent

• US121584682024

  Fab-linked Glycans as Biomarker for the Transition from a Pre-disease “at-risk-phase” to Rheumatoid Arthritis; AAV or Sjögren Syndrome

  Academisch Ziekenhuis Leiden H.o.d.n. LUMC

  0 cites